Spain ,Europe, March 2026 — Dr Muriel DONA-FOLOGO CANUT has started her new role as Head of Regulatory Affairs EU Region (Global Regulatory Affairs) at GSK, taking on executive leadership responsibility for regulatory strategy across Europe.
In her new position as Executive Director, Head of GRA Europe Region, Dr Muriel leads the Regulatory Affairs function across Tier 1, Tier 2 Local Operating Companies (LOCs), and cluster markets, overseeing a team of 165 professionals. She is responsible for driving the strategic regulatory agenda in the region, ensuring regulatory compliance, protecting corporate reputation, and aligning submission strategies with R&D, commercial, and regional objectives. She also plays a key role in accelerating major submissions and contributing strategically as a member of the EU Commercial Leadership Team.
Prior to joining GSK, Dr Muriel served as Corporate Head of Regulatory Affairs at Neuraxpharm, where she developed and implemented global regulatory strategies across innovative, generic, orphan, and value-added medicines. She led major engagements with regulatory agencies including the EMA and local authorities, established new regulatory affiliates, defined regulatory priorities, and aligned regulatory roadmaps with commercial and market access objectives.
Earlier, she held multiple senior global regulatory leadership roles at Takeda, including Senior Director, Global Regulatory Affairs – Oncology TA Lead, and Senior Director, Regulatory Affairs (Emerging Markets – International RA). In these roles, she provided strategic regulatory expertise across oncology, rare diseases, plasma-derived therapies, neurosciences, gastrointestinal, vaccines, and primary care portfolios. She led regulatory teams across Growth and Emerging Markets and ensured alignment between global, regional, and local regulatory strategies.
Her earlier career includes senior regulatory leadership roles at Sanofi, Biogen, Abbott, and the Merck Group, where she built deep expertise in international product registrations, life-cycle management, compliance, and global regulatory operations.
With more than two decades of international regulatory leadership experience across major global biopharmaceutical organizations, Dr Muriel DONA-FOLOGO CANUT’s appointment strengthens GSK’s regulatory capabilities across Europe at a critical time for innovation and market expansion.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. The company prioritizes innovation in specialty medicines and vaccines to prevent and treat disease worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
